New Research: 2 stocks to buy as Nifty50 heads towards 40,000
Here is the latest financial fact sheet of WANBURY. For more details, see the WANBURY quarterly results and WANBURY share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 4.6 |
No. of shares | m | 32.75 |
1 Week | % | 16.7 |
1 Month | % | -11.8 |
1 Year | % | 285.4 |
52 week H/L | Rs | 177.4/34.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
WANBURY EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 38 | 33 | 115 | 115 | 90 | |
Low | Rs | 15 | 11 | 16 | 64 | 33 | |
Sales per share (Unadj.) | Rs | 165.0 | 147.0 | 156.9 | 156.5 | 152.8 | |
Earnings per share (Unadj.) | Rs | -10.5 | 25.8 | -5.0 | 24.9 | -3.2 | |
Diluted earnings per share | Rs | -7.6 | 19.7 | -3.8 | 24.9 | -3.2 | |
Cash flow per share (Unadj.) | Rs | -6.3 | 29.7 | -1.1 | 28.4 | 0.6 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | -88.3 | -57.5 | -62.6 | -7.5 | -10.5 | |
Adj. book value per share | Rs | -64.0 | -43.9 | -47.8 | -7.4 | -10.5 | |
Shares outstanding (eoy) | m | 23.72 | 25.00 | 25.02 | 32.67 | 32.71 | |
Price / Sales ratio | x | 0.2 | 0.2 | 0.4 | 0.6 | 0.4 | |
Avg P/E ratio | x | -2.5 | 0.9 | -13.0 | 3.6 | -19.3 | |
P/CF ratio (eoy) | x | -4.2 | 0.7 | -57.5 | 3.1 | 100.8 | |
Price / Book Value ratio | x | -0.3 | -0.4 | -1.0 | -12.0 | -5.8 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 631 | 553 | 1,640 | 2,915 | 2,004 | |
Total wages/salary | Rs m | 757 | 675 | 641 | 748 | 810 |
WANBURY INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,914 | 3,675 | 3,925 | 5,112 | 4,996 | |
Other income | Rs m | 115 | 462 | 48 | 51 | 10 | |
Total revenues | Rs m | 4,029 | 4,137 | 3,973 | 5,163 | 5,007 | |
Gross profit | Rs m | 134 | 610 | 157 | 1,081 | 225 | |
Depreciation | Rs m | 100 | 97 | 98 | 115 | 124 | |
Interest | Rs m | 399 | 329 | 231 | 206 | 214 | |
Profit before tax | Rs m | -250 | 647 | -124 | 811 | -103 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -1 | 2 | 2 | -3 | 1 | |
Profit after tax | Rs m | -248 | 645 | -126 | 815 | -104 | |
Gross profit margin | % | 3.4 | 16.6 | 4.0 | 21.1 | 4.5 | |
Effective tax rate | % | 0.5 | 0.3 | -1.6 | -0.4 | -1.1 | |
Net profit margin | % | -6.3 | 17.5 | -3.2 | 15.9 | -2.1 |
WANBURY BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 982 | 936 | 975 | 1,712 | 1,222 | |
Current liabilities | Rs m | 3,616 | 3,110 | 3,554 | 3,598 | 3,204 | |
Net working cap to sales | % | -67.3 | -59.2 | -65.7 | -36.9 | -39.7 | |
Current ratio | x | 0.3 | 0.3 | 0.3 | 0.5 | 0.4 | |
Inventory Days | Days | 3 | 4 | 4 | 3 | 4 | |
Debtors Days | Days | 414 | 505 | 321 | 448 | 497 | |
Net fixed assets | Rs m | 1,845 | 1,817 | 1,823 | 1,737 | 1,742 | |
Share capital | Rs m | 237 | 250 | 250 | 327 | 327 | |
"Free" reserves | Rs m | -2,332 | -1,687 | -1,816 | -570 | -672 | |
Net worth | Rs m | -2,095 | -1,437 | -1,566 | -243 | -344 | |
Long term debt | Rs m | 1,230 | 995 | 720 | 0 | 0 | |
Total assets | Rs m | 2,827 | 2,753 | 2,835 | 3,469 | 2,984 | |
Interest coverage | x | 0.4 | 3.0 | 0.5 | 4.9 | 0.5 | |
Debt to equity ratio | x | -0.6 | -0.7 | -0.5 | 0 | 0 | |
Sales to assets ratio | x | 1.4 | 1.3 | 1.4 | 1.5 | 1.7 | |
Return on assets | % | 5.3 | 35.4 | 3.7 | 29.4 | 3.7 | |
Return on equity | % | 11.9 | -44.9 | 8.1 | -334.7 | 30.2 | |
Return on capital | % | -17.2 | -221.0 | -12.6 | -417.9 | -32.2 | |
Exports to sales | % | 47.3 | 48.9 | 56.1 | 54.9 | 58.0 | |
Imports to sales | % | 15.8 | 7.9 | 12.4 | 20.1 | 20.5 | |
Exports (fob) | Rs m | 1,850 | 1,796 | 2,201 | 2,808 | 2,899 | |
Imports (cif) | Rs m | 618 | 290 | 488 | 1,029 | 1,024 | |
Fx inflow | Rs m | 1,899 | 1,836 | 2,272 | 2,949 | 2,997 | |
Fx outflow | Rs m | 667 | 322 | 505 | 1,079 | 1,072 | |
Net fx | Rs m | 1,232 | 1,513 | 1,767 | 1,870 | 1,925 |
WANBURY CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 297 | 441 | 167 | 405 | 198 | |
From Investments | Rs m | -31 | 637 | 80 | 6 | -88 | |
From Financial Activity | Rs m | -268 | -1,079 | -174 | -286 | -320 | |
Net Cashflow | Rs m | -1 | -1 | 73 | 125 | -210 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
COMP SEC: Jitendra J Gandhi | YEAR OF INC: 1988 | BSE CODE: 524212 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare WANBURY With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.